<code id='3827EFAB06'></code><style id='3827EFAB06'></style>
    • <acronym id='3827EFAB06'></acronym>
      <center id='3827EFAB06'><center id='3827EFAB06'><tfoot id='3827EFAB06'></tfoot></center><abbr id='3827EFAB06'><dir id='3827EFAB06'><tfoot id='3827EFAB06'></tfoot><noframes id='3827EFAB06'>

    • <optgroup id='3827EFAB06'><strike id='3827EFAB06'><sup id='3827EFAB06'></sup></strike><code id='3827EFAB06'></code></optgroup>
        1. <b id='3827EFAB06'><label id='3827EFAB06'><select id='3827EFAB06'><dt id='3827EFAB06'><span id='3827EFAB06'></span></dt></select></label></b><u id='3827EFAB06'></u>
          <i id='3827EFAB06'><strike id='3827EFAB06'><tt id='3827EFAB06'><pre id='3827EFAB06'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:5

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Will the market for weight loss drugs really reach $100 billion?
          Will the market for weight loss drugs really reach $100 billion?

          DamianGardeofSTAT,left,talkedwithLiisaBaykoofEvercoreISIandJaredHolzofMizuhoabouttheGLP-1weightlossm

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          As biotech industry slumps, bioscience job market is upside down

          ChristineKao/STATAfterearningherdoctorateincellbiologyattheUniversityofPennsylvaniainJune,SierraColl